InfraReDx, Inc., a Burlington, MA-based medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases, has received a $10m senior secured multi-draw term loan from GE Capital, Healthcare Financial Services.
InfraReDx intends to use the financing for product commercialization efforts.
Led by president and CEO Donald Southard, the company develops intelligent imaging technologies to advance the diagnosis and treatment of coronary heart disease. Its TVC Imaging System™ is an intravascular imaging system providing information critical for evaluating vessel structure and chemical composition, helping to more fully characterize a vessel.
The system is cleared by the U.S. Food and Drug Administration for the detection of lipid core plaques of interest, which are known to complicate stenting and are believed to cause the majority of heart attacks.